Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene

Annals of the New York Academy of Sciences

Volumn 1106, Issue , 2007, Pages 95-113

  Li, Zhixiong ^a   Kustikova, Olga S ^a,b   Kamino, Kenji ^a   Neumann, Thomas ^a   Rhein, Mathias ^a   Grassman, Elke ^c   Fehse, Boris ^b   Baum, Christopher ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Histiocytic sarcoma; Insertional mutagenesis; Myeloid leukemia; Retroviral vectors; Simian virus 40

Indexed keywords

AXL PROTEIN; CHAPERONE; CRK LIKE PROTEIN; CSFR1 PROTEIN; FLI PROTEIN; HSPA4 PROTEIN; LIF PROTEIN; MAX PROTEIN; OSM PROTEIN; PDGFRB PROTEIN; PROTEIN BCL X; PROTEIN DERIVATIVE; PROTEIN KINASE PIM 2; PROTEIN P53; RETINOBLASTOMA PROTEIN; RETROVIRUS VECTOR; SEMA4B PROTEIN; TRANSCRIPTION FACTOR SOX4; UNCLASSIFIED DRUG; VIRUS LARGE T ANTIGEN; VIRUS T ANTIGEN;

APOPTOSIS; BONE MARROW; BONE MARROW TRANSPLANTATION; CANCER RESEARCH; CELL CULTURE; CELL LINE; CELL TRANSPLANTATION; CONFERENCE PAPER; EVALUATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INSERTION; GENE REPLICATION; GENE TRANSFER; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HISTIOCYTE; INJECTION; KINETICS; LIGATION; MITOGENESIS; MODULATION; MONOCYTIC LEUKEMIA; MYELOID LEUKEMIA; NONHUMAN; ONCOGENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTO ONCOGENE; SARCOMA CELL; SIMIAN VIRUS 40; SOMATIC GENE THERAPY; SOUTHERN BLOTTING; SURVIVAL; T ONCOGENE; TRANSGENICS; ANIMAL; ARTICLE; BONE MARROW CELL; C3H MOUSE; C57BL MOUSE; CYTOLOGY; GENE VECTOR; GENETICS; HISTIOCYTIC LYMPHOMA; METABOLISM; MOUSE; MUTAGENESIS; PHYSIOLOGY; RETROVIRUS; STEM CELL; TUMOR SUPPRESSOR GENE;

MUS; SIMIAN VIRUS 40;

ANIMALS; ANTIGENS, VIRAL, TUMOR; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; GENES, P53; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; LYMPHOMA, LARGE-CELL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MUTAGENESIS; RETROVIRIDAE; STEM CELLS;

EID: 34548431065     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1392.003     Document Type: Conference Paper

References (37)

1. KUSTIKOVA, O.S. et al. 2005. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308: 1171-1174.
2. MODLICH, U. et al. 2005. Leukemias following retroviral transfer of multidrug resistance 1 are driven by combinatorial insertional mutagenesis. Blood 105: 4235-4246.
3. MIKKERS, H. & A. BERNS. 2003. Retroviral insertional mutagenesis: tagging cancer pathways. Adv. Cancer Res. 88: 53-99.
4. AKAGI, K. et al. 2004. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32: D523-D527.
5. LI, Z. et al. 2002. Murine leukemia induced by retroviral gene marking. Science 296: 497.
6. HACEIN-BEY-ABINA, S. et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
7. BAUM, C. et al. 2003. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101: 2099-2114.
8. DAVÉ, U., N.A. JENKINS & N.G. COPELAND. 2004. Gene therapy insertional mutagenesis insights. Science 303: 333.
9. DU, Y. et al. 2005. Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood 106: 2498-2505.
10. SAENZ-ROBLES, M.T., C.S. SULLIVAN & J.M. PIPAS. 2001. Transforming functions of Simian Virus 40. Oncogene 20: 7899-7907.
11. SULLIVAN, C.S. & J.M. PIPAS. 2002. T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol. Mol. Biol. Rev. 66: 179-202.
12. GAZDAR, A.F., J.S. BUTEL & M. CARBONE. 2002. SV40 and human tumours: myth, association or causality? Nat. Rev. Cancer 2: 957-964.
13. DAVID, H. et al. 2001. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett. 162: 57-64.
14. SHIVAPURKAR, N. et al. 2002. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 359: 851-852.
15. RHIM, J.S. et al. 1990. Evidence for the multistep nature of in vitro human epithelial cell carcinogenesis. Cancer Res. 50: S5653-S5657.
16. HAHN, W.C. & R.A. WEINBERG. 2002. Rules for making human tumor cells. N. Engl. J. Med. 347: 1593-1603.
17. KONE, J. et al. 2002. F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4. Leukemia 16: 1827-1834.
18. GILLET, R. et al. 2002. Effect of Bcl-2 expression on hepatic preneoplasia in mice. Cancer Lett. 177: 189-195.
19. SCHWIEGER, M. et al. 2002. AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency. J. Exp. Med. 196: 1227-1240.
20. FEHSE, B. et al. 2000. CD34 splice variant: an attractive marker for selection of gene-modified cells. Mol. Ther. 1: 448-456.
21. WILL, E. et al. 2006. HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cues. Cell Cycle 5: 14-22.
22. KRAUNUS, J. et al. 2004. Self-inactivating retroviral vectors with improved RNA processing. Gene Ther. 11: 1568-1578.
23. LI, Z. et al. 2003. Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose. Exp. Hematol. 31: 1206-1214.
24. SCHMIDT, M. et al. 2001. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum. Gene Ther. 12: 743-749.
25. MIZUKI, M. et al. 2000. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood 96: 3907-3914.
26. LEE, W.P. et al. 2002. Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis. Oncogene 21: 329-336.
27. HOFMANN, M.C. et al. 2003. Establishment and characterization of neonatal mouse sertoli cell lines. J. Androl. 24: 120-130.
28. LIU, Z.Y. et al. 1997. Characterization of signal transduction pathways in human bone marrow endothelial cells. Blood 90: 2253-2259.
29. FLETCHER, F.A. et al. 1991. Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo. J. Exp. Med. 174: 837-845.
30. BUSSLINGER, M. 2004. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22: 55-79.
31. CAMERON, E.R. & J.C. NEIL. 2004. The Runx genes: lineage-specific oncogenes and tumor suppressors. Oncogene 23: 4308-4314.
32. MORENO, C.S. et al. 2004. Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown. Cancer Res. 64: 6978-6988.
33. WHITE, E. 2003. The pims and outs of survival signaling: role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev. 17: 1813-1816.
34. TAKAHASHI, K., K. MITSUI & S. YAMANAKA. 2003. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423: 541-545.
35. CASILLAS, M.A. et al. 2003. Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Gene 316: 57-65.
36. DICK, J.E. 2003. Stem cells: Self-renewal writ in blood. Nature 423: 231-233.
37. JAMIESON, C.H. et al. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351: 657-667.